- Conditions
- Central Centrifugal Cicatricial Alopecia, Frontal Fibrosing Alopecia
- Interventions
- Deucravacitinib
- Drug
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- New York, New York
Source: ClinicalTrials.gov public record
Updated May 10, 2026 · Synced May 22, 2026, 12:15 AM EDT